DalsnaFinance

Becton Dickinson $BDX

Health Care · Health Care Equipment · NYSE/NASDAQ

S&P 500 Russell 1000 New Jersey
Create a scorecard
$193.76
+4.87 (+2.58%)
As of Oct 15, 2026, 9:53 PM EDT
Price history
Loading chart…

Becton Dickinson (BDX) is trading up at $193.76 (+2.58%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Becton Dickinson revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)
$21.8B$10.9B$0FY2016 revenue: $12.5BFY2016 net income: $976.0M · Net margin 7.8%'16FY2017 revenue: $12.1BFY2017 net income: $1.10B · Net margin 9.1%'17FY2018 revenue: $16.0BFY2018 net income: $311.0M · Net margin 1.9%'18FY2019 revenue: $17.3BFY2019 net income: $1.23B · Net margin 7.1%'19FY2020 revenue: $16.1BFY2020 net income: $874.0M · Net margin 5.4%'20FY2021 revenue: $19.1BFY2021 net income: $2.09B · Net margin 10.9%'21FY2022 revenue: $18.9BFY2022 net income: $1.78B · Net margin 9.4%'22FY2023 revenue: $19.4BFY2023 net income: $1.48B · Net margin 7.7%'23FY2024 revenue: $20.2BFY2024 net income: $1.71B · Net margin 8.4%'24FY2025 revenue: $21.8BFY2025 net income: $1.68B · Net margin 7.7%'250%5%10%15%FY2016 net margin: 7.8%FY2017 net margin: 9.1%FY2018 net margin: 1.9%FY2019 net margin: 7.1%FY2020 net margin: 5.4%FY2021 net margin: 10.9%FY2022 net margin: 9.4%FY2023 net margin: 7.7%FY2024 net margin: 8.4%FY2025 net margin: 7.7%
Becton Dickinson annual financial statements
FY2016Sep 2016FY2017Sep 2017FY2018Sep 2018FY2019Sep 2019FY2020Sep 2020FY2021Sep 2021FY2022Sep 2022FY2023Sep 2023FY2024Sep 2024FY2025Sep 2025
Income statement
Revenue$12.5B$12.1B$16.0B$17.3B$16.1B$19.1B$18.9B$19.4B$20.2B$21.8B
Growth (year over year)+21.4%−3.1%+32.2%+8.2%−7.0%+19.0%−1.4%+2.7%+4.2%+8.2%
Gross profit$5.99B$5.94B$7.27B$8.29B$7.58B$8.63B$8.48B$8.17B$9.13B$9.93B
Gross margin48.0%49.1%45.5%47.9%47.1%45.1%44.9%42.2%45.2%45.4%
Operating income$1.43B$1.52B$1.51B$1.76B$912.0M$2.25B$2.28B$2.11B$2.40B$2.58B
Operating margin11.5%12.6%9.4%10.2%5.7%11.8%12.1%10.9%11.9%11.8%
Net income$976.0M$1.10B$311.0M$1.23B$874.0M$2.09B$1.78B$1.48B$1.71B$1.68B
Net margin7.8%9.1%1.9%7.1%5.4%10.9%9.4%7.7%8.4%7.7%
EPS (diluted)$4.49$4.60$0.60$3.94$2.71$6.85$5.88$4.94$5.86$5.82
Balance sheet
Cash and equivalents$1.54B$14.2B$1.14B$536.0M$2.83B$2.28B$1.01B$1.42B$1.72B$567.0M
Total assets$25.6B$37.7B$53.9B$51.8B$54.0B$53.9B$52.9B$52.8B$57.3B$55.3B
Total liabilities$18.0B$24.8B$32.9B$30.7B$30.2B$30.2B$27.7B$27.0B$31.4B$29.9B
Long-term debt$10.6B$18.7B$18.9B$18.1B$17.2B$17.1B$13.9B$14.7B$17.9B$17.6B
Shareholders' equity$7.63B$12.9B$21.0B$21.1B$23.8B$23.7B$25.3B$25.8B$25.9B$25.4B
Cash flow
Operating cash flow$2.56B$2.55B$2.87B$3.33B$3.54B$4.65B$2.47B$2.99B$3.84B$3.43B
Capital expenditure$693.0M$727.0M$895.0M$957.0M$769.0M$1.19B$973.0M$874.0M$725.0M$760.0M
Free cash flow$1.87B$1.82B$1.97B$2.37B$2.77B$3.45B$1.50B$2.12B$3.12B$2.67B
Dividends paid$562.0M$677.0M$927.0M$984.0M$1.03B$1.05B$1.08B$1.11B$1.10B$1.20B
Share buybacks$0$220.0M$0$0$0$1.75B$500.0M$0$500.0M$1.00B

From Becton Dickinson's 10-K and 10-Q filings with the SEC; its fiscal year ends in September. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

About Becton Dickinson

Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.

Source: Wikipedia — BD (company)

Headquarters
Franklin Lakes, New Jersey From SEC filings, Oct 2026

Recent News (19)

More Health Care stocks

Browse all companies →